HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Victor G Prieto Selected Research

Nevus (Nevi)

10/2020TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis.
11/2018Detection of a MicroRNA molecular signature of ultraviolet radiation in the superficial regions of melanocytic nevi on sun-exposed skin.
1/2017Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
4/2016BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression.
4/2013Differential expression of the G-protein-coupled formyl Peptide receptor in melanoma associates with aggressive phenotype.
4/2010Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases.
4/2010Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
3/2010State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop.
8/2009Atypical histologic and immunohistochemical findings in melanocytic nevi after liquid nitrogen cryotherapy.
1/2009Lack of maturation with anti-leptin receptor antibody in melanoma but not in nevi.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Victor G Prieto Research Topics

Disease

111Neoplasms (Cancer)
09/2022 - 02/2002
107Melanoma (Melanoma, Malignant)
10/2022 - 02/2002
26Neoplasm Metastasis (Metastasis)
06/2021 - 02/2002
18Nevus (Nevi)
10/2020 - 05/2003
15Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2021 - 03/2006
13Carcinoma (Carcinomatosis)
09/2022 - 01/2006
8Mycosis Fungoides
11/2019 - 04/2003
7Pigmented Nevus (Melanocytic Nevus)
11/2021 - 01/2002
7Sarcoma (Soft Tissue Sarcoma)
04/2021 - 04/2003
6Merkel Cell Carcinoma
09/2022 - 04/2007
6Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2017 - 08/2002
6Dysplastic Nevus Syndrome (Dysplastic Nevus)
03/2010 - 11/2003
5Breast Neoplasms (Breast Cancer)
06/2021 - 07/2009
5Lymphoma (Lymphomas)
05/2021 - 02/2007
5Dermatitis
10/2020 - 02/2017
4Skin Diseases (Skin Disease)
03/2022 - 12/2012
4Lymphatic Metastasis
03/2016 - 03/2002
4Actinic Keratosis
07/2014 - 06/2008
4Keratoacanthoma
07/2014 - 06/2008
4Carcinogenesis
05/2010 - 04/2006
4Renal Cell Carcinoma (Grawitz Tumor)
04/2010 - 05/2007
3Basal Cell Carcinoma (Rodent Ulcer)
01/2020 - 05/2008
3Inflammation (Inflammations)
11/2019 - 01/2009
3Keratosis
09/2019 - 02/2013
3Necrosis
01/2019 - 08/2004
3Bullous Pemphigoid (Pemphigoid)
10/2018 - 08/2016
3Hemangiosarcoma (Angiosarcoma)
06/2018 - 01/2013
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2018 - 01/2015
3Exanthema (Rash)
12/2017 - 01/2009
3Cicatrix (Scar)
12/2015 - 08/2002
3Skin Neoplasms (Skin Cancer)
04/2012 - 12/2005
2Residual Neoplasm
09/2022 - 04/2010
2Hyperphosphatemia
03/2021 - 10/2018
2Hyperpigmentation
05/2020 - 12/2015
2Acrospiroma
08/2019 - 04/2010
2Fever (Fevers)
01/2019 - 12/2016
2Blister (Bulla)
07/2018 - 08/2016
2Panniculitis
12/2017 - 08/2015
2Disease Progression
08/2017 - 01/2009
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
04/2017 - 01/2014

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2002
18Biomarkers (Surrogate Marker)IBA
11/2020 - 12/2006
15ParaffinIBA
11/2019 - 10/2002
13Biological ProductsIBA
09/2021 - 08/2004
13Formaldehyde (Formol)FDA Link
11/2019 - 10/2002
9AntigensIBA
10/2022 - 05/2007
9Immune Checkpoint InhibitorsIBA
05/2021 - 01/2017
9Imatinib Mesylate (Gleevec)FDA Link
04/2010 - 08/2002
7RNA (Ribonucleic Acid)IBA
04/2021 - 08/2004
7VemurafenibIBA
03/2016 - 12/2012
6Monoclonal AntibodiesIBA
05/2021 - 02/2004
6Keratins (Keratin)IBA
01/2020 - 03/2004
6DNA (Deoxyribonucleic Acid)IBA
11/2019 - 12/2009
5Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022 - 04/2003
5S100 Proteins (S 100 Protein)IBA
04/2021 - 05/2003
5pembrolizumabIBA
01/2021 - 08/2016
5Messenger RNA (mRNA)IBA
01/2021 - 10/2004
5dabrafenibIBA
09/2019 - 02/2013
5AntibodiesIBA
09/2019 - 01/2006
5LigandsIBA
05/2019 - 01/2006
5MART-1 AntigenIBA
08/2017 - 07/2009
5ErbB Receptors (EGF Receptor)IBA
03/2014 - 12/2004
4CTLA-4 AntigenIBA
07/2018 - 01/2017
4Transcription Factors (Transcription Factor)IBA
03/2018 - 12/2005
4Melanins (Melanin)IBA
08/2017 - 01/2002
4Sorafenib (BAY 43-9006)FDA Link
03/2014 - 06/2008
4Platelet-Derived Growth FactorIBA
06/2011 - 04/2006
3NivolumabIBA
01/2021 - 08/2016
3Estrogen ReceptorsIBA
01/2021 - 10/2011
3IpilimumabIBA
01/2021 - 01/2017
3Pharmaceutical PreparationsIBA
12/2019 - 08/2002
3CytokinesIBA
11/2019 - 05/2012
3Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 10/2004
3MicroRNAs (MicroRNA)IBA
11/2018 - 06/2013
3Monophenol Monooxygenase (Tyrosinase)IBA
09/2017 - 06/2014
3Indicators and Reagents (Reagents)IBA
11/2016 - 01/2011
3Carcinoembryonic AntigenIBA
06/2014 - 05/2009
3Mucin-1 (CA 15-3 Antigen)IBA
06/2014 - 10/2007
3Androgen Receptors (Androgen Receptor)IBA
01/2014 - 09/2005
3Hormones (Hormone)IBA
01/2014 - 08/2004
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
04/2007 - 01/2003
2Coloring Agents (Dyes)IBA
09/2022 - 02/2014
2Telomerase (Telomerase Reverse Transcriptase)IBA
03/2022 - 01/2021
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 08/2004
2Cyclin D1IBA
04/2021 - 04/2016
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2020 - 02/2017
2Paclitaxel (Taxol)FDA LinkGeneric
06/2018 - 03/2016
2Brentuximab VedotinIBA
05/2018 - 12/2016
2Eosine Yellowish-(YS) (Eosin)IBA
01/2018 - 05/2009
2Hematoxylin (Haematoxylon)IBA
01/2018 - 05/2009
2VimentinIBA
08/2017 - 10/2013
2Capsules (Microcapsules)IBA
01/2017 - 05/2003

Therapy/Procedure

69Therapeutics
09/2022 - 02/2002
10Drug Therapy (Chemotherapy)
09/2022 - 10/2004
9Aftercare (After-Treatment)
01/2021 - 08/2002
8Radiotherapy
01/2016 - 03/2002
7Immunotherapy
09/2022 - 08/2016
7Lymph Node Excision (Lymph Node Dissection)
12/2019 - 07/2002
2Neoadjuvant Therapy
05/2021 - 07/2018
2Debridement
01/2019 - 10/2004